Showing results (1441-1450 of 1,493) with videos related to

Sort By:
Pageof 150
Gastroenterology|December 13, 2012
A dominant CD4(+) T-cell response to Helicobacter pylori reduces risk for gastric disease in humansLi Chen, Bin Li, Wu-Chen Yang, et al.
BMC Infectious Diseases|April 18, 2015
Characterizing the epidemiology, virology, and clinical features of influenza in China's first severe acute respiratory infection sentinel surveillance system, February 2011-October 2013Zhibin Peng, Luzhao Feng, Greene M Carolyn, et al.
Nature|May 8, 2020
Isolation of SARS-CoV-2-related coronavirus from Malayan pangolinsKangpeng Xiao, Junqiong Zhai, Yaoyu Feng, et al.
European Radiology|November 23, 2022
Ultrasound-based deep learning in the establishment of a breast lesion risk stratification system: a multicenter studyYang Gu, Wen Xu, Ting Liu, et al.
Plant Biotechnology Journal|March 23, 2023
Poaceae-specific β-1,3;1,4-d-glucans link jasmonate signalling to OsLecRK1-mediated defence response during rice-brown planthopper interactionsYang-Shuo Dai, Di Liu, Wuxiu Guo, et al.
The American Journal of Surgical Pathology|May 17, 2019
Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord DifferentiationCheng-Han Lee, Yu-Chien Kao, Wan-Ru Lee, et al.
Insights Into Imaging|July 28, 2022
Deep learning based on ultrasound images assists breast lesion diagnosis in China: a multicenter diagnostic studyYang Gu, Wen Xu, Bin Lin, et al.
Nucleic Acids Research|October 30, 2014
A cytoplasmic RNA virus generates functional viral small RNAs and regulates viral IRES activity in mammalian cellsKuo-Feng Weng, Chuan-Tien Hung, Po-Ting Hsieh, et al.
The Lancet. Oncology|October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 6, 2022
[Reflections on supervision strategies of new Tibetan drug registration]Dan Liang, Tsring Pemba, Jiang-Yong Yu, et al.
Pageof 150